NASDAQ
Karuna Therapeutics, Inc. (KRTX) has a price/fcf ratio of -30.09x as of Monday, May 25, 2026. This represents a 8.21% increase compared to its 12-month average of -32.78x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.